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Abstract
Objectives This study analyses the changes in smoking habits
over the course of 1 year in a group of patients referred to an
oral medicine unit.
Materials and methods Smoking history and behaviour were
analysed at baseline and after 1 year based on a self-reported
questionnaire and on exhaled carbonmonoxide levels [in parts
per million (ppm)]. During the initial examination, all smokers
underwent tobacco use prevention and cessation counselling.
Results Of the initial group of 121 patients, 98 were examined
at the follow-up visit. At the baseline examination, 33 patients
(33.67 %) indicated that they were current smokers. One year
later, 14 patients (42.24 % out of the 33 smokers of the initial
examination) indicated that they had attempted to stop
smoking at least once over the follow-up period and
15.15 % (5 patients) had quit smoking. The mean number of
cigarettes smoked per day by current smokers decreased from
13.10 to 12.18 (p=0.04). The exhaled CO level measurements
showed very good correlation with a Spearman's coefficient
0.9880 for the initial visit, and 0.9909 for the follow-up
examination. For current smokers, the consumption of one
additional cigarette per day elevated the COmeasurements by
0.77 ppm (p<0.0001) at the baseline examination and by
0.84 ppm (p<0.0001) at the 1-year follow-up.
Conclusions In oral health care, where smoking cessation is
an important aspect of the treatment strategy, the measure-
ment of exhaled carbon monoxide shows a very good corre-
lation with a self-reported smoking habit.
Clinical relevance Measurement of exhaled carbon monox-
ide is a non-invasive, simple and objective measurement
technique for documenting and monitoring smoking cessa-
tion and reduction.
Keywords Smoking . Self-reported . Exhaled carbon
monoxide . Smoking cessation . Dental setting
Introduction
According to the World Health Organization (WHO),
smoking continues to be the leading global cause of prevent-
able death. Each year, it kills nearly six million people and
causes economic damage worldwide [1]. In Switzerland,
27 % of the population are current smokers (30 % of the
males and 24 % of the females), consuming on average 11.5
cigarettes per day [2].
As there is a strong dose–response relationship between
the use of tobacco and the development of oral pathologies
such as oral cancer, tobacco use cessation or reduction is a
main goal in public health [3]. It has been reported that
intervention delivered by oral health care professionals in-
creases the odds of quitting tobacco consumption [4]. There-
fore, there have been numerous efforts to promote tobacco
use prevention and cessation counselling (TUPAC) in the
field of dental medicine [5, 6].
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In the dental setting, smoking habits are mainly self-
reported using questionnaires, as most oral health profes-
sionals do not have the necessary equipment to perform
objective analyses of smoking habits and/or exposure to
tobacco smoke, such as measurement of cotinine levels in
saliva, blood or urine [7, 8] or spirometry [9]. As self-
reporting of tobacco use has been reported to underestimate
the true amount of smoking in comparison to biochemical
methods [10, 11], there is a need for a non-invasive, simple
and objective measurement technique to document and mon-
itor smoking cessation and reduction in patients at risk.
The primary objective of the present study was to docu-
ment the evolution and changes of smoking habits of patients
treated in an oral medicine unit over the course of 1 year using
TUPAC combined with measurements of exhaled carbon
monoxide (CO) levels.
Material and methods
Study sample and clinical examination
This study was designed as a follow-up study investigating
the smoking behaviour and the effect of TUPAC combined
with measurement of exhaled CO levels on patients referred
to an oral medicine unit at the University of Bern with various
lesions of the oral mucosa ranging from benign/reactive to
premalignant lesions and conditions between September and
December 2010. The primary outcome parameters included
the smoking cessation rate, the changes of measured exhaled
CO levels over the course of 1 year, and the correlation
between self-reported smoking status and exhaled CO levels
in the two examinations. The secondary outcome parameters
included dynamic changes in questionnaire data analysis such
as number of cigarettes consumed per day or the mean pack-
year value. A previous paper compares the initial data of this
group to results of a group of patients recruited from daily
outpatient service [12]. All patients examined in the oral
medicine unit for the first study were scheduled for a follow-
up visit to reassess their smoking habits 1 year later.
At the initial examination and at the follow-up examina-
tion, patients filled in a questionnaire about their smoking
behaviour. Specifically, patients were asked at the initial ex-
amination about their awareness of a potential benefit of
smoking cessation and willingness to quit smoking during
the next 6 months. Afterwards, at each time point, two mea-
surements of their exhaled CO levels were taken (piCO+
Smokerlyzer, Bedfont Scientific Ltd., Kent, UK). Besides
these examinations, all patients referred with stomatological
lesions were examined following the protocol of the oral
medicine unit of the University of Bern (thorough medical
history, recent dental/stomatological history, extra- and
intraoral examination, oral biopsy and radiographic imaging
when necessary). All smokers underwent TUPAC stage 2
(further basic care) as proposed by the Consensus Report of
the Second European Workshop on Tobacco Use Prevention
and Cessation for oral health professionals, including brief
intervention (assess tobacco use and readiness to quit, brief
counselling for smoking cessation/behavioural intervention
and request permission to re-address tobacco use at the sub-
sequent visit) and provision of support for cessation [6]. The
study protocol was approved by the standing ethics committee
for clinical studies in the state of Bern.
Assessment of smoking status and questionnaire data
Before commencement of the follow-up examination, all
patients filled in a standardised questionnaire regarding their
smoking habits for comparison with their initial anamnestic
data. This questionnaire asked whether patients were never
smokers, former smokers or current smokers. The current
and former smokers had to indicate the number of cigarettes
smoked per day (including the time period since they started
smoking) to allow for calculation of a pack-year value.
Additionally, smokers were asked to indicate if they had
tried to quit smoking since the initial examination.
Exhaled carbon monoxide levels
Exhaled carbon monoxide (CO) levels were measured in all
patients using a specialised monitoring device. To ensure that
measurements were standardised, patients were asked to ex-
hale completely, take a deep breath, and hold it for 15 s before
exhaling fully and slowly into the mouthpiece of the monitor.
Furthermore, patients were instructed to seal their lips tightly
around the mouthpiece so that no air escaped from the mea-
suring device while they were exhaling [13, 14]. The device
measures the exhaled CO concentration in parts per million
(ppm) with a range from 0 to 100. The manufacturer states that
the device is accurate to ±2 % based on the repeatability of
readings (http://www.bedfont.com/smokerlyzer/pico+). The
CO measurements were classified into four groups: three are
based on recommendations of the manufacturer: 0–10 ppm,
non-/former smokers; 11–25 ppm, light smokers and >25 ppm,
heavy smokers. The first group was additionally divided into
two groups (0–6 and 7–10 ppm), as some studies propose a
cutoff level of 5 ppm [15] or 6 ppm [14] between smokers and
non-smokers. For all study participants, a total of four CO
values were measured—two at the initial and two at the
follow-up examination—to validate the reproducibility of
the method. The CO monitoring device was calibrated
every 6 months over the course of the study according
to manufacturer instructions. All CO level measurements
were taken by two experienced senior residents (OEB andMF).
The COmeasurements were scheduled between 10:00 a.m. and
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noon for all patients, and were performed prior to any further
clinical examination or intervention.
Statistical analysis
First, all data were analysed using descriptive statistics.
Between-group differences in continuous and categorical
variables were compared using the t test or chi square test
where appropriate. The association between exhaled CO
levels and current smoking status, cumulative pack-year
values, and number of cigarettes per day was evaluated using
a linear regression model, adjusted for age and sex, both at
baseline and follow-up examination.
The significance level chosen for all statistical tests was
p≤0.05. All statistical analyses were performed using the
software package Stata 11.1 (StataCorp, College Station,
Texas, USA).
Results
Study population
A total of 121 patients were included in the initial examination,
with 98 re-examined at a follow-up exam 1 year later. The
initial group comprised 77 patients with benign/reactive lesions,
and in 44 subjects premalignant lesions and conditions were
present. Nomalignant mucosal disease was diagnosed in any of
the included patients. Twenty-three members of the initial
group were lost to follow-up: three patients had died since the
initial examination, two were hospitalised and could not come
to the clinic, two hadmoved abroad, seven could not be reached
(phone or mail), and nine declined to come for the follow-up
visit. The group analysed in the present study comprised 33
male and 65 female subjects with a mean age of 59.4 years
(minimum, 17 years; maximum, 84 years).
Questionnaire analysis
The patient pool was devided into three groups according to
smoking behaviour at baseline: 33 patients (33.67 %) reported
that they were current smokers, 28 patients (28.57 %) were
former smokers and 37 (37.76 %) had never been smokers. At
the follow-up visit 1 year later, 28 patients (28.57%) indicated
that they were current smokers, 33 (33.67 %) were former
smokers and 37 (37.76 %) had never been smokers (Fig. 1).
Among the smokers, five patients reported to have stopped
smoking since the initial evaluation resulting in a 15.15 %
cessation rate. Out of these five patients, four were initially
diagnosed with benign/reactive lesions, and one patient
presented with a premalignant lesion (oral leukoplakia). For
12 patients, the amount of cigarettes consumed per day
remained unchanged, 10 had reduced and 6 had increased
their amount of cigarettes smoked per day. The mean number
of cigarettes per day among current smokers decreased from
13.10 to 12.18 over the course of 1 year, which proved to be
statistically significant (p=0.04). The mean pack-year value
among current smokers and former smokers increased from
22.23 to 22.91 (p=0.3313; Table 1).
At the initial examination, 24 patients (72.72 % out of 33
current smokers) indicated to be aware of a potential benefit
of smoking cessation, and 16 patients (48.48 %) were willing
to stop smoking during the next 6 months. During the
follow-up examination, 14 patients (42.24 % out of the 33
smokers of the initial examination) indicated that they had
attempted to stop smoking at least once over the follow-up
period (Table 2).
Exhaled CO level analysis
The mean value of the two exhaled CO measurements for the
98 patients was 6.46 ppm at the initial examination and
7.00 ppm at the 1-year follow-up visit. The data exhibited
very good correlations for the two exhaled CO measurements
taken for each patient, with a Spearman's coefficient of 0.9880
for the initial visit, and 0.9909 for the follow-up examination.
Because almost identical exhaled CO values were measured
during the same visit, only the initial measurement was used
for further analyses. The difference between these CO values
from the two examinations was not statistically significant
(p=0.4535).
At the initial examination, current smokers exhibited a mean
exhaled CO level of 14.24 ppm (Table 3). This value slightly
increased at the 1-year follow-up visit (16.14 ppm). For former
smokers, the mean exhaled CO level increased from 2.96 to
3.30 ppm during the period of the baseline and the follow-up
Fig. 1 Smoking behaviour of the included patients over the course of
1 year as assessed using self-reported questionnaire data
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examination. For people who had never smoked, the mean
exhaled CO level increased without significance from the
baseline to the follow-up examination (from 2.24 to 3.37 ppm).
Correlation between self-reported data and exhaled CO
levels
In both examinations, the highest exhaled CO values were
found for current smokers, which proved to be statistically
significant in comparison to former smokers and never
smokers (p<0.001 for both visits; Table 4). Furthermore, the
CO measurements were statistically significantly influenced
by the pack-year values (p=0.005 for the initial visit; p=0.006
for the 1-year follow-up visit), and the number of cigarettes
smoked per day for the initial visit (p<0.001). For current and
former smokers, the consumption of 1 pack-year more
resulted in an increase of the exhaled CO value by 0.15 ppm
(95 % CI, 0.05–0.26 ppm; p=0.005) for the baseline exami-
nation, and by 0.15 ppm (95 % CI, 0.05–0.26 ppm; p=0.006)
for the 1-year follow-up examination. For current smokers, the
consumption of one additional cigarette per day elevated the
CO measurements by 0.77 ppm (95 % CI, 0.64–0.90 ppm;
p<0.0001) for the baseline examination, and by 0.84 ppm
(95 %CI, 0.70–0.98 ppm; p<0.0001) for the 1-year follow-up
examination.
Discussion
At the initial examination of the present study, the percentage
of patients indicating they were current smokers (33.67 %)
was slightly higher than the prevalence reported in Switzer-
land (27 %) [2]. This may be due to the fact that all patients
had been referred by dental professionals or physicians for
further evaluation and therapy of suspected pathologies of
their oral mucosa, which are often related to present or
former smoking habits [16]. At the follow-up examination
after 1 year, the percentage of current smokers had decreased
to 28.27 %. Of the initial 33 smokers, five (15.15 %) had
stopped smoking in the year between the two exams.
Despite dental professionals' known discomfort over offer-
ing smoking cessation during routine dental care [17, 18], it is
now widely recognised that the dental professional plays a
major role in tobacco use prevention and cessation counselling,
also when compared with the role of general healthcare practi-
tioners [4, 19]. In previous studies, smoking habits were mainly
recorded using only self-reported data, which is likely to be
subjective and unreliable. It has been shown that self-reported
data often underestimate the true prevalence of tobacco con-
sumption [8, 10], even more when the patients analysed had
been specifically motivated for smoking cessation (pregnant
women [20] or patients suffering from chronic obstructive
pulmonary disease [11]). The lack of reliability of anamnestic
data on smoking habits is also demonstrated in our study, where
the data collected for calculation of a pack-year value at base-
line and at the follow-up examination showed a lack of con-
gruence, e.g. initial never smokers reported they were former
smokers and former smokers reported they were never smokers
at the follow-up visit.
The most objective and accurate method of evaluating
tobacco use is biochemical measurement of cotinine (a metab-
olite of nicotine) levels in saliva or urine [21]. Tests using
Table 1 Characteristics of the patients examined in 2010 and 2011 regarding self-reported data on smoking habits (smoking status, cumulative pack-
year value and number of cigarettes smoked per day)
Never smokers
(% in group)
Current smokers
(% in group)
Former smokers
(% in group)
Mean py (95 % CI)a Mean number of cigarettes
per day (range)b
Initial visit (2010) 37 (37.76) 33 (33.67) 28 (28.57) 22.23 (16.56–27.91) 13.10* (0–40)
Follow-up (2011) 37 (37.76) 28 (28.57) 33 (33.67) 22.91 (16.91–28.92) 12.18* (0–40)
py cumulative pack-year value, 95% CI 95 % confidence interval
*p=0.04 (statistically significant difference)
a Current and former smokers
b Current smokers
Table 2 Questionnaire data evaluating willingness to quit smoking, awareness of a potential benefit of smoking cessation, and attempts to quit
smoking for current smokers in the initial and follow-up examination
No Yes Missing
Awareness of a potential benefit of smoking cessation (2010, n=33) 7 (21.21 %) 24 (72.72 %) 2 (6.06)
Willingness to quit smoking in the next 6 months (2010, n=33) 17 (51.51 %) 16 (48.48 %) –
Attempts to quit smoking during the last year (2011, n=33a) 18 (54.55 %) 14 (42.42 %) 1 (3.03 %)
a n=33: 28 smokers and 5 patients that stopped smoking during the follow-up period
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cotinine levels provide high sensitivity (93–95 %) and speci-
ficity (100 %). Furthermore, cotinine has a long half-life
(15–20 h) and is specific to tobacco use.
The measurement of exhaled CO levels provides an ac-
ceptable degree of discrimination of current smokers and is
considerably cheaper and simpler to use when compared to
cotinine measurements [21]. The level of exhaled CO is in
equilibrium with the level of carboxyhaemoglobin in arterial
blood (COHb). When the patient is breathing room air, the
half-life of COHb is 5 to 6 h [14]. This explains why
recording smoking habits using the measurement of exhaled
CO is vulnerable to external sources of CO such as environ-
mental pollution, passive smoke, occupational exposure or
occult CO poisoning, and to the time since the last cigarette
has been smoked. The measurement of exhaled CO levels
has the advantage of showing an immediate result without
being invasive, and with high sensitivity (94 %) and speci-
ficity (96 %) [14].
To obtain comparable results in the present study, all exhaled
CO level measurements were taken between 10:00 a.m. and
noon. Studies show that the measurement of exhaled CO levels
gives amore accurate indication of the current smoking status if
the last cigarette has been smoked 5 [15] to 8 h [22] before the
measurement is taken. Therefore, clinicians should be aware of
the risk that patients could have smoked their last cigarette in
the evening/night prior to the scheduled appointment, thus
resulting in low CO values that could wrongfully be interpreted
as measurements from a never or former smoker due to the
short half-life time of CO [23].
The results of the present study show a strong association
between self-reported smoking habits and the measurement
of exhaled CO levels (Tables 3 and 4). The present study
corroborates data from a previous study [12], assessing ex-
haled CO levels of patients from an oral medicine unit and
daily outpatient service upon initial presentation. Neverthe-
less, exhaled CO levels were not yet analysed over a defined
period of time in a dental setting, thus also exhibiting the
dynamic changes of measured CO levels within the same
patients. In the present study, all but one of the patients
indicating to be never smokers or former smokers exhibited
exhaled CO values under or equal to 10 ppm, which is the
threshold recommended by the manufacturer between
non-/former smokers and light smokers. Possible explana-
tions for the higher CO level (15 ppm) found in one of the
former smokers at the initial examination include exposure
to an external CO source or a persisting smoking habit. The
same patient showed an exhaled CO value of 3 ppm at the
follow-up examination 1 year later.
Compared with other studies assessing the results of
TUPAC showing cessation rates between 7 and 36.4 % for
high-intensity interventions, and between 4 and 13 % for brief
interventions [24–28], the 15.15 % cessation rate found in the
present study at the 1-year follow-up after only a brief inter-
vention including the measurement of exhaled CO levels is
quite promising. For the smokers included in the present study,
the data on awareness of a potential benefit of smoking ces-
sation (72.72%) and on thewillingness to quit smoking during
the next 6 months (48.48%) are comparable with findings of a
previous study from Bornstein and coworkers [29]. This study
demonstrated that patients diagnosed with benign/reactive
lesions show less willingness to quit smoking than patients
with premalignant or malignant diseases of the oral mucosa.
This could not be confirmed in present study, where 4 out of
the 5 patients that reported to have stopped smoking since the
initial evaluation in the current analysis were initially diag-
nosed with benign/reactive lesions. Nevertheless, the exact
reason or motivation for smoking cessation for each individual
patient was not evaluated in the present study.
Table 3 Exhaled CO values (ppm) for current smokers, former
smokers and never smokers examined in 2010 and 2011
Never smokers Current smokers Former smokers
Initial visit (2010) (n=37) (n=33) (n=28)
Mean 2.24* 14.24 2.96
Maximum 10 43 15
Minimum 1 2 1
95 % CI 1.73–2.75 10.67–17.80 1.87–4.05
Follow-up (2011) (n=37) (n=28) (n=33)
Mean 3.37* 16.14 3.30
Maximum 10 41 8
Minimum 1 1 1
95 % CI 2.86–3.89 12.29–19.99 2.64–3.95
*p<0.05 (statistically significant difference)
Table 4 Correlation between self-reported smoking status and correspond-
ing exhaled CO values (in ppm) in the patients examined in 2010 and 2011
Never
smokers
Former
smokers
Current
smokers
Total
Initial visit (2010)
CO values
0–6 ppm 36 25 9 70
7–10 ppm 1 2 6 9
11–25 ppm 0 1 13 14
>25 ppm 0 0 5 5
Total 37 28 33 98
Follow-up (2011)
CO values
0–6 ppm 36 29 6 71
7–10 ppm 1 4 4 9
11–25 ppm 0 0 13 13
> 25 ppm 0 0 5 5
Total 37 33 28 98
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That smoking cessation needs to be an integral component
to effectively manage patients attending an oral medicine
clinic has been clearly stated in the literature [30]. The results
regarding willingness to quit (48.48 %) and the smoking
cessation attempts (42.42 %) during the last year in a dental
setting are clearly higher than data reported for the whole
Swiss population [2]. For this general population, a willing-
ness to quit in the next 6 months of 26 % was documented,
and 19 % of the subjects reported smoking cessation at-
tempts during the last year. For the present study, having
been referred by dental professionals or physicians for fur-
ther evaluation and therapy of suspected pathologies of the
oral mucosa may have influenced this increased awareness
of potential harmful effects of tobacco and the willingess to
quit smoking. Combined with the brief intervention, all
smokers received at the initial examination, this could have
resulted in the high smoking cessation rate of 15.15 %.
The effect of the feedback and motivation the patients got
from the repeated objective measurements of exhaled CO has
not yet been analysed successfully in the literature and should
be addressed in future studies [31]. Only with a clear added
value ofmotivating smokers to quit, the additional costs for the
acquisition of a CO measurement device can be justified for
daily practice in a dental medicine setting. A study evaluating
the effect of the measurement of salivary cotinine levels as a
motivational tool included in TUPAC showed a strong associ-
ation between the use of the biochemical method for assess-
ment of smoking behaviour and increased quit rates (23 versus
7 % for controls) after 8 weeks [32].
One limitation of the present study is that the number of
patients lost to follow-up was quite high (19 %). This problem
is widely recognised in smoking cessation trials. The studies
cited above reported lost-to-follow-up rates of 24.33 [24],
50.84 [25], 28.89 [26], 51.95 [27] and 26.78 % [28]. Another
important limitation of the study is that the group of current
smokers presenting at both visits (initial and follow-up) was
small, thus the percentage of quitters (15.15 %, five patients)
could be overestimated. One reason is that out of the 23
members of the initial group that were lost to follow-up, 11
had been current smokers at the initial visit. Therefore, a larger
cohort and a longer follow-up period are needed to allow for a
more refined analysis of the group of current smokers.
Another important limitation of the present study is the
fact that all smokers underwent the same TUPAC combined
with the monitoring of exhaled CO values without a control
group. Therefore, it is not possible to estimate the added
effect of the monitoring of exhaled CO values in comparison
to patients receiving brief intervention for smoking cessation
alone. Nevertheless, the primary outcome of this study was to
monitor the evolution and changes of smoking habits in a
dental setting using questionnaire data and TUPAC combined
with measurement of exhaled CO values. For future studies,
further evaluation of the effectiveness of exhaled CO level
measurements as an easy, robust and non-invasive method for
motivation of patients undergoing TUPAC in a dental setting
should be undertaken. Additionally, studies are needed to
establish the best time of day to measure exhaled CO values
for assessing TUPAC outcomes with regard to the last ciga-
rette smoked.
Conclusions
Measurement of exhaled carbon monoxide is a non-invasive,
simple and objective measurement technique for documenting
and monitoring smoking cessation and reduction. In oral
health care units, where smoking cessation is an important
aspect of the treatment strategy, the measurement of exhaled
carbon monoxide shows a very good correlation with self-
reported smoking habits. Documenting how the measurement
of exhaled CO levels could influence or motivate smoking
cessation efforts in a dental setting is an important goal for
future research.
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